Skip to main content
. 2022 Jun 22;158(8):954–956. doi: 10.1001/jamadermatol.2022.2100

Table. Demographic Characteristics and Systemic Treatment of Study Patients (N = 39).

Characteristic Patients, No. (%)
Age, median (range), y 59 (20-82)
Female 16 (41.0)
Male 23 (59.0)
Race and ethnicity
Asian 7 (18.0)
Black/African American 3 (7.7)
Hispanic/Latino 6 (15.4)
White 15 (38.5)
Othera 8 (21)
Systemic treatment (n = 10)
Bexarotene/acitretin 6 (60.0)
Methotrexate 3 (30.0)
Doxorubicin 1 (10.0)
a

Other included not recorded, declined to answer, and unknown race or ethnicity.